» Articles » PMID: 18173882

Excess Mortality and Risk Factors for Mortality Among a Cohort of TB Patients from Rural South India

Overview
Specialty Pulmonary Medicine
Date 2008 Jan 5
PMID 18173882
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: To estimate the excess general mortality among tuberculosis (TB) patients in a rural area (Tiruvallur) and identify risk factors for TB-related mortality.

Setting: The study population consisted of all TB patients aged >or=15 years who were registered under the Revised National Tuberculosis Control Programme (RNTCP) during the years 2000 to 2003 at Velliyur TB unit (TU) in south India.

Design: This is a retrospective cohort study of 3405 patients treated under the DOTS strategy, followed up from the date of start of treatment till the date of interview (for the survivors) or the date of death (for those who died).

Results: There were 2710 (79.6%) survivors and 695 (20.4%) deaths. The excess general mortalities for the cohort, expressed as standardised mortality ratio (SMR), was 4.2 (95%CI 3.9-4.5). High SMR values were obtained for patients belonging to the 15-44 years age group (12.1), patients on Category II regimen (9.3), treatment failures (9.1) and defaulters (7.8). The adjusted hazards ratios (aHR) were high for patients aged 45-59 years (1.9), >or=60 years (3.1) and with incomplete treatment due to default or failure (6.4).

Conclusion: TB is one of the main causes of mortality in the younger age group. Among TB patients, the major risk factors for mortality are old age (>or=45 years) and incomplete treatment.

Citing Articles

HIV co-infection increases the risk of post-tuberculosis mortality among persons who initiated treatment for drug-resistant tuberculosis.

Salindri A, Kipiani M, Lomtadze N, Tukvadze N, Avaliani Z, Blumberg H Sci Rep. 2024; 14(1):23834.

PMID: 39394335 PMC: 11470076. DOI: 10.1038/s41598-024-68605-2.


Impact of pyrazinamide usage on serious adverse events in elderly tuberculosis patients: A multicenter cohort study.

Yoon J, Kim T, Kim J, Kim H, Lee E, Jung S PLoS One. 2024; 19(9):e0309902.

PMID: 39325726 PMC: 11426458. DOI: 10.1371/journal.pone.0309902.


Barriers to engagement in the care cascade for tuberculosis disease in India: A systematic review of quantitative studies.

Jhaveri T, Jhaveri D, Galivanche A, Lubeck-Schricker M, Voehler D, Chung M PLoS Med. 2024; 21(5):e1004409.

PMID: 38805509 PMC: 11166313. DOI: 10.1371/journal.pmed.1004409.


Effect of smoking cessation interventions on abstinence and tuberculosis treatment outcomes among newly diagnosed patients: a randomized controlled trial.

Khan M, Zaheer S, Amar W, Shafique K Microbiol Spectr. 2024; 12(4):e0387823.

PMID: 38385711 PMC: 10986535. DOI: 10.1128/spectrum.03878-23.


HIV co-infection increases the risk of post-tuberculosis mortality among persons who initiated treatment for drug-resistant tuberculosis.

Salindri A, Kipiani M, Lomtadze N, Tukvadze N, Avaliani Z, Blumberg H medRxiv. 2023; .

PMID: 37293036 PMC: 10246159. DOI: 10.1101/2023.05.19.23290190.